A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals
- 29 June 2010
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 53 (4) , 599-607
- https://doi.org/10.1016/j.jhep.2010.05.007
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Human dendritic cells pulsed with specific lipopeptides stimulate autologous antigen-specific T cells without the addition of exogenous maturation factorsJournal of Viral Hepatitis, 2008
- Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41Gastroenterology, 2008
- Inhibition of HIV‐1 or bacterial activation of macrophages by products of HIV‐1‐resistant human cellsImmunology & Cell Biology, 2007
- Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 ExpressionJournal of Virology, 2007
- Defining target antigens for CD25+FOXP3+IFN‐γ− regulatory T cells in chronic hepatitis C virus infectionImmunology & Cell Biology, 2007
- Evasion of intracellular host defence by hepatitis C virusNature, 2005
- Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis CThe Journal of Infectious Diseases, 2005
- Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donorsJournal of Hepatology, 2005
- Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C VirusJournal of Virology, 2004
- An ELISA for the detection of antibody to the core antigen of hepatitis C virus: use in diagnosis and analysis of indeterminate samplesJournal of Hepatology, 1996